{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T22:12:51Z","timestamp":1758406371784,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-023-03283-6","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T02:01:34Z","timestamp":1691114494000},"page":"689-697","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The impact of boost radiation therapy after hysterectomy on cervical cancer patients with close or positive resection margins"],"prefix":"10.1007","volume":"26","author":[{"given":"So Jung","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myungsoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoo-Kang","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4206-8674","authenticated-orcid":false,"given":"Hye Jin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,4]]},"reference":[{"key":"3283_CR1","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.2147\/OTT.S186451","volume":"12","author":"H Zhao","year":"2019","unstructured":"Zhao H, He Y, Yang SL, Zhao Q, Wu YM. Neoadjuvant chemotherapy with radical surgery vs radical surgery alone for cervical cancer: a systematic review and meta-analysis. Onco Targets Ther. 2019;12:1881\u201391.","journal-title":"Onco Targets Ther"},{"key":"3283_CR2","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1056\/NEJMoa1806395","volume":"379","author":"PT Ramirez","year":"2018","unstructured":"Ramirez PT, Frumovitz M, Pareja R, Lopez A, Vieira M, Ribeiro R, et al. Minimally invasive versus abdominal radical hysterectomy for cervical cancer. N Engl J Med. 2018;379:1895\u2013904.","journal-title":"N Engl J Med"},{"key":"3283_CR3","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1200\/JCO.19.03012","volume":"38","author":"S Uppal","year":"2020","unstructured":"Uppal S, Gehrig PA, Peng K, Bixel KL, Matsuo K, Vetter MH, et al. Recurrence rates in patients with cervical cancer treated with abdominal versus minimally invasive radical hysterectomy: a multi-institutional retrospective review study. J Clin Oncol. 2020;38:1030\u201340.","journal-title":"J Clin Oncol"},{"key":"3283_CR4","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1006\/gyno.1996.4576","volume":"64","author":"RA Samlal","year":"1997","unstructured":"Samlal RA, van der Velden J, Schilthuis MS, Gonz\u00e1lez Gonz\u00e1lez D, Ten Kate FJ, Hart AA, et al. Identification of high-risk groups among node-positive patients with stage IB and IIA cervical carcinoma. Gynecol Oncol. 1997;64:463\u20137.","journal-title":"Gynecol Oncol"},{"key":"3283_CR5","doi-asserted-by":"publisher","first-page":"5686","DOI":"10.1038\/s41598-018-23403-5","volume":"8","author":"RK Orosco","year":"2018","unstructured":"Orosco RK, Tapia VJ, Califano JA, Clary B, Cohen EEW, Kane C, et al. Positive surgical margins in the 10 most common solid cancers. Sci Rep. 2018;8:5686.","journal-title":"Sci Rep"},{"key":"3283_CR6","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.ijrobp.2006.03.010","volume":"65","author":"AN Viswanathan","year":"2006","unstructured":"Viswanathan AN, Lee H, Hanson E, Berkowitz RS, Crum CP. Influence of margin status and radiation on recurrence after radical hysterectomy in Stage IB cervical cancer. Int J Radiat Oncol Biol Phys. 2006;65:1501\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3283_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3857\/roj.2015.33.2.109","volume":"33","author":"YJ Kim","year":"2015","unstructured":"Kim YJ, Lee KJ, Park KR, Kim J, Jung W, Lee R, et al. Prognostic analysis of uterine cervical cancer treated with postoperative radiotherapy: importance of positive or close parametrial resection margin. Radiat Oncol J. 2015;33:109\u201316.","journal-title":"Radiat Oncol J"},{"key":"3283_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.brachy.2011.08.005","volume":"11","author":"W Small Jr","year":"2012","unstructured":"Small W Jr, Beriwal S, Demanes DJ, Dusenbery KE, Eifel P, Erickson B, et al. American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy. Brachytherapy. 2012;11:58\u201367.","journal-title":"Brachytherapy"},{"key":"3283_CR9","unstructured":"National Comprehensive Cancer Network. Cervical cancer (Version 1.2023). 2023. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cervical.pdf. Accessed 15 Jan 2023."},{"key":"3283_CR10","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events v5.0. https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcae_v5_quick_reference_5x7.pdf. Accessed 15 Jan 2023."},{"key":"3283_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1148\/radiol.2019190088","volume":"292","author":"SI Lee","year":"2019","unstructured":"Lee SI, Atri M. 2018 FIGO staging system for uterine cervical cancer: enter cross-sectional imaging. Radiology. 2019;292:15\u201324.","journal-title":"Radiology"},{"key":"3283_CR12","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3857\/roj.2018.00087","volume":"36","author":"D Kim","year":"2018","unstructured":"Kim D, Ki Y, Kim W, Park D, Lee J, Lee J, et al. Adjuvant external beam radiation and brachytherapy for vaginal resection margin positive cervical cancer. Radiat Oncol J. 2018;36:147\u201352.","journal-title":"Radiat Oncol J"},{"key":"3283_CR13","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s10147-021-02037-0","volume":"27","author":"YH Lee","year":"2022","unstructured":"Lee YH, Kim YS, Choi KH, Sung S, Jeong BK, Ha IB, et al. Comparison of treatment outcomes of pelvis external radiotherapy with and without vaginal brachytherapy for cervical cancer patients with positive or close vaginal resected margins. Int J Clin Oncol. 2022;27:202\u201312.","journal-title":"Int J Clin Oncol"},{"key":"3283_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/COC.0000000000000607","volume":"43","author":"BJ Ager","year":"2020","unstructured":"Ager BJ, Torgeson A, Francis SR, Burt LM, Gaffney DK, Cannon DM. Impact of brachytherapy boost and dose-escalated external beam radiotherapy in margin positive cervical cancer treated with chemotherapy and radiation. Am J Clin Oncol. 2020;43:35\u201342.","journal-title":"Am J Clin Oncol"},{"key":"3283_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0360-3016(94)00391-W","volume":"31","author":"RG Stock","year":"1995","unstructured":"Stock RG, Chen AS, Flickinger JC, Kalnicki S, Seski J. Node-positive cervical cancer: impact of pelvic irradiation and patterns of failure. Int J Radiat Oncol Biol Phys. 1995;31:31\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3283_CR16","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1136\/ijgc-2020-001412","volume":"30","author":"J Contreras","year":"2020","unstructured":"Contreras J, Srivastava A, Chundury A, Schwarz JK, Markovina S, Thaker PH, et al. Long-term outcomes of intensity-modulated radiation therapy (IMRT) and high dose rate brachytherapy as adjuvant therapy after radical hysterectomy for cervical cancer. Int J Gynecol Cancer. 2020;30:1157\u201361.","journal-title":"Int J Gynecol Cancer"},{"key":"3283_CR17","unstructured":"Gynecologic Oncology Group. Chemotherapy and pelvic radiation therapy with or without additional chemotherapy in treating patients with high-risk early-stage cervical cancer after radical hysterectomy. NLM identifier: NCT00980954. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00980954 Accessed 10 Jan 2023."},{"key":"3283_CR18","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1034\/j.1600-0412.2002.811208.x","volume":"81","author":"N Takeda","year":"2002","unstructured":"Takeda N, Sakuragi N, Takeda M, Okamoto K, Kuwabara M, Negishi H, et al. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy. Acta Obstet Gynecol Scand. 2002;81:1144\u201351.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"3283_CR19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/1097-0142(19920101)69:1<181::AID-CNCR2820690130>3.0.CO;2-B","volume":"69","author":"T Kamura","year":"1992","unstructured":"Kamura T, Tsukamoto N, Tsuruchi N, Saito T, Matsuyama T, Akazawa K, et al. Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy. Cancer. 1992;69:181\u20136.","journal-title":"Cancer"},{"key":"3283_CR20","doi-asserted-by":"publisher","first-page":"e380","DOI":"10.1111\/ajco.12997","volume":"14","author":"R Du","year":"2018","unstructured":"Du R, Li L, Ma S, Tan X, Zhong S, Wu M. Lymph nodes metastasis in cervical cancer: incidences, risk factors, consequences and imaging evaluations. Asia Pac J Clin Oncol. 2018;14:e380\u20135.","journal-title":"Asia Pac J Clin Oncol"},{"key":"3283_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S1053-4296(00)80021-1","volume":"10","author":"WJ Koh","year":"2000","unstructured":"Koh WJ, Panwala K, Greer B. Adjuvant therapy for high-risk, early stage cervical cancer. Semin Radiat Oncol. 2000;10:51\u201360.","journal-title":"Semin Radiat Oncol"},{"key":"3283_CR22","doi-asserted-by":"publisher","first-page":"485","DOI":"10.21037\/atm.2020.03.27","volume":"8","author":"Q Guo","year":"2020","unstructured":"Guo Q, Zhu J, Wu Y, Wen H, Xia L, Ju X, et al. Validation of the prognostic value of various lymph node staging systems for cervical squamous cell carcinoma following radical surgery: a single-center analysis of 3732 patients. Ann Transl Med. 2020;8:485.","journal-title":"Ann Transl Med"},{"key":"3283_CR23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1046\/j.1525-1438.1999.09895.x","volume":"9","author":"CH Lai","year":"1999","unstructured":"Lai CH, Hsueh S, Hong JH, Chang TC, Tseng CJ, Chou HH, et al. Are adenocarcinomas and adenosquamous carcinomas different from squamous carcinomas in stage IB and II cervical cancer patients undergoing primary radical surgery? Int J Gynecol Cancer. 1999;9:28\u201336.","journal-title":"Int J Gynecol Cancer"},{"key":"3283_CR24","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ygyno.2005.05.026","volume":"99","author":"G Van de Putte","year":"2005","unstructured":"Van de Putte G, Lie AK, Vach W, Baekelandt M, Kristensen GB. Risk grouping in stage IB squamous cell cervical carcinoma. Gynecol Oncol. 2005;99:106\u201312.","journal-title":"Gynecol Oncol"},{"key":"3283_CR25","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/jog.13282","volume":"43","author":"M Takekuma","year":"2017","unstructured":"Takekuma M, Kasamatsu Y, Kado N, Kuji S, Tanaka A, Takahashi N, et al. The issues regarding postoperative adjuvant therapy and prognostic risk factors for patients with stage I-II cervical cancer: a review. J Obstet Gynaecol Res. 2017;43:617\u201326.","journal-title":"J Obstet Gynaecol Res"},{"key":"3283_CR26","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/bjc.2013.716","volume":"110","author":"SY Ryu","year":"2014","unstructured":"Ryu SY, Kim MH, Nam BH, Lee TS, Song ES, Park CY, et al. Intermediate-risk grouping of cervical cancer patients treated with radical hysterectomy: a Korean gynecologic oncology group study. Br J Cancer. 2014;110:278\u201385.","journal-title":"Br J Cancer"},{"key":"3283_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1006\/gyno.2000.6010","volume":"80","author":"F Landoni","year":"2001","unstructured":"Landoni F, Maneo A, Cormio G, Perego P, Milani R, Caruso O, et al. Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: a prospective randomized study. Gynecol Oncol. 2001;80:3\u201312.","journal-title":"Gynecol Oncol"},{"key":"3283_CR28","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2018.29.e91","author":"K Matsuo","year":"2018","unstructured":"Matsuo K, Mandelbaum RS, Machida H, Purushotham S, Grubbs BH, Roman LD, et al. Association of tumor differentiation grade and survival of women with squamous cell carcinoma of the uterine cervix. J Gynecol Oncol. 2018. https:\/\/doi.org\/10.3802\/jgo.2018.29.e91.","journal-title":"J Gynecol Oncol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-023-03283-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-023-03283-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-023-03283-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T09:16:51Z","timestamp":1707988611000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-023-03283-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,4]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["3283"],"URL":"https:\/\/doi.org\/10.1007\/s12094-023-03283-6","relation":{},"ISSN":["1699-3055"],"issn-type":[{"type":"electronic","value":"1699-3055"}],"subject":[],"published":{"date-parts":[[2023,8,4]]},"assertion":[{"value":"25 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the institutional review board of the Catholic Medical Center ethics committee (IRB No.: OC22RASI0154).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No informed consent was required for this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}